Aspen Neuroscience’s Personalized Parkinson’s Therapy Shows Promise in Clinical Trial
For the millions of people living with Parkinson’s disease, the search for effective treatments is a constant source of hope and concern. Current therapies manage symptoms but do not stop the progression of the disease. However, recent advancements in cell therapy are offering a new frontier in the fight against Parkinson’s. A New Era for […]
Kenai Therapeutics Gets $8M Boost for Parkinson’s Treatment
A New Hope for Parkinson’s Patients Kenai Therapeutics, a San Diego-based biotechnology company, has received an $8 million grant from the California Institute for Regenerative Medicine (CIRM). This funding will help advance their lead program, RNDP-001, a promising new treatment for idiopathic Parkinson’s disease. The grant was awarded to Dr. Howard J. Federoff, the company’s […]
Parkinson’s Symptoms Reversed: A Stem Cell Breakthrough?
For the 10 million people worldwide living with Parkinson’s disease, the daily battle with tremors, stiffness, and loss of motor control is a constant reality. But a groundbreaking clinical trial in China has delivered a powerful new sense of hope, as a 37-year-old woman has achieved a “functional cure” just three months after receiving a […]
New Hope for Parkinson’s Patients: Cell Therapy Shows Promise
For individuals with Parkinson’s disease (PD), the progressive loss of motor function presents a daily challenge. The search for effective treatments has led researchers to explore cell replacement therapy, and recent findings have generated significant optimism. New Studies Report Positive Trends Two studies, released at the International Congress of Parkinson’s Disease and Movement Disorders®, have […]
Aspen Neuroscience Advances Parkinson’s Treatment with New Trial Phase
More than one million people in the U.S. live with Parkinson’s disease, a condition with no available disease-modifying therapies. A new development from Aspen Neuroscience offers a potential new direction, as the company initiates a new phase in its clinical trial for a personalized cell therapy. ASPIRO Trial Enters Third Cohort Aspen Neuroscience has announced […]
BlueRock Therapeutics Announces First Patient Treated in Pivotal Phase III Parkinson’s Trial
BlueRock Therapeutics, a subsidiary of Bayer, has announced a significant milestone in the development of a new treatment for Parkinson’s disease. The first patient has been treated in their pivotal Phase III clinical trial, known as exPDite-2. This trial will evaluate the safety and effectiveness of bemdaneprocel, an investigational cell therapy. The trial is the first […]
Stem Cell Research for Parkinson’s: What Patients Need to Know
Is stem cell therapy a viable treatment for Parkinson’s disease? What are the real risks and benefits? In a recent webinar from The Michael J. Fox Foundation for Parkinson’s Research, leading experts shared the latest advances in stem cell science and what they mean for patients. This article summarizes the key takeaways from the webinar, […]
Trailhead Biosystems Launches New iPSC-Derived A9 Dopaminergic Neurons to Advance Parkinson’s Research
Trailhead Biosystems, Inc., a biotechnology company focused on creating induced pluripotent stem cell (iPSC)-derived human cells for drug discovery and cell therapy, today announced the launch of TrailBio® A9 Dopaminergic Neurons. This new product provides researchers with a critical tool for studying Parkinson’s disease and other neurodegenerative conditions. A9 dopaminergic neurons are essential for regulating […]
How Exercise Supercharges Stem Cell Therapy for Parkinson’s Disease
In the latest episode of The Stem Cell Report podcast, host Janet Rossant delves into groundbreaking research that explores the synergistic effects of exercise and stem cell therapy in treating Parkinson’s disease. Joined by Dr. Clare Parish and Dr. Niamh Moriarty from The Florey Institute of Neuroscience and Mental Health, the discussion centers on their […]
Stem Cells, Exosomes, and Parkinson’s Disease: A New Hope
Infinite Health Integrative Medicine Center in Louisiana announced progress in Parkinson’s disease treatment through stem cell and exosome innovations. A Phase 1 clinical trial is reprogramming stem cells to replace damaged neurons, showing potential in early results. Dr. Trip Goolsby’s center is using a less invasive exosome therapy to repair brain damage and improve dopamine production. […]